NCT00960141View on ClinicalTrials.gov

A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

829

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

October 31, 2000

Study Completion Date

November 30, 2000

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

montelukast sodium

montelukast 10 mg tablet, taken orally once daily at bed time for 2 weeks

DRUG

Comparator: loratadine

loratadine 10 mg tablet, taken orally once daily at bed time for 2 weeks

DRUG

Comparator: placebo

placebo tablet, taken orally once daily at bed time for 2 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00960141 - A Study Investigating the Effect of Montelukast in Patients With Seasonal Allergic Rhinitis (MK-0476-192)(COMPLETED) | Biotech Hunter | Biotech Hunter